Fairvalue-Calculator Fairvalue-Calculator
EN DE

NeuroOne Medical Technologies Corporation (NMTC) Fair Value & Analysis

Healthcare · US · Market cap $28.6M

Price$3.35
Fair Value$3.66
Upside+9.3%
Quality95/100
Evidence: Low Range $2.74 – $4.57

Fair value as of: Jun 24, 2026

Analysis

NeuroOne Medical Technologies Corporation (NMTC) currently trades at $3.35, while our model-based Fair Value estimate is $3.66 — implying the stock looks roughly 9.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is NeuroOne Medical Technologies Corporation (NMTC) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $3.66 versus a price of $3.35 — about +9% (undervalued). Model-based estimate, not financial advice.
What is the fair value of NMTC?
Our 21-model fair value for NeuroOne Medical Technologies Corporation is $3.66 (as of Jun 24, 2026), built from audited fundamentals. The current price is $3.35.
What is the quality score of NMTC?
NeuroOne Medical Technologies Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.